Centessa Pharmaceuticals plc American Depositary Shares

CNTA XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

6.2B

Short interest (May 15)

1.6%

Net Short (Jun 03 ): -0.1%

Borrow Fee

0.43%

↑ 3.5%

Available Shares

↑ 1.3%

Price Chart

Company Overview

Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001847903

Asset Type: ADRC

Market Data

Market Cap: $6,173,685,743

Employees: 129

Status: Active

Short Interest

Current Borrow Fee 0.43%

Range: 0.43% - 0.44%

Available Shares 4M

Range: 1.7M - 3.7M

Recent Changes

Fee Change: ↑ 2.9%

Available Change: ↓ 1.4%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime